Correct Answer: A. C3b
C3b is the larger fragment generated when complement component C3 is cleaved during complement activation. It acts as a primary opsonin by covalently binding to pathogen surfaces and marking them for destruction. Phagocytes (neutrophils, macrophages) express complement receptors (CR1, CR3, CR4) that recognize and bind C3b-coated antigens, dramatically enhancing phagocytosis—a process called complement-mediated opsonization. This is the most important biological function of C3b in innate immunity. In Indian clinical practice, deficiencies in C3 or its regulatory proteins (like Factor H) lead to recurrent infections and post-infectious glomerulonephritis, highlighting C3b's critical role in pathogen clearance. The opsonization function is distinct from the anaphylatoxin activity seen with smaller fragments (C3a, C5a), making C3b unique as both a structural complement component and an immune enhancer.
Why the other options are wrong
B. C3a — C3a is the small anaphylatoxin fragment released during C3 cleavage, not an opsonin. It acts as a potent chemotactic agent and mast cell degranulator, triggering inflammation and vasodilation. While C3a is biologically active, it does NOT enhance phagocytosis or coat pathogens for destruction—the defining feature of an opsonin. This is a classic NBE trap pairing C3 with its fragments without distinguishing their functions. C. C6 — C6 is a membrane attack complex (MAC) component involved in the terminal complement pathway (C5b-C9), responsible for creating pores in pathogen membranes and causing lysis. It has no opsonizing activity and does not enhance phagocytosis. This option tests whether students confuse complement components by their numerical order rather than understanding their distinct biological roles in immunity. D. C5a — C5a is the second major anaphylatoxin generated during complement activation, even more potent than C3a in triggering inflammation, chemotaxis, and neutrophil activation. Like C3a, it is a soluble mediator of inflammation, not an opsonin. Students often confuse anaphylatoxins (C3a, C5a) with opsonic fragments (C3b, iC3b), a common error in complement physiology.
High-Yield Facts
- C3b is the primary complement opsonin; it covalently binds pathogen surfaces and enhances phagocytosis via CR1/CR3/CR4 on phagocytes.
- C3a and C5a are anaphylatoxins (inflammatory mediators), not opsonic fragments—they trigger mast cell degranulation and chemotaxis.
- iC3b (inactive C3b) is also opsonic but weaker than C3b; it binds CR2 on B cells and follicular dendritic cells.
- C3 deficiency in Indian populations increases susceptibility to encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) and post-streptococcal glomerulonephritis.
- MAC components (C5b-C9) cause membrane lysis; they are not opsonic and do not enhance phagocytosis.
Mnemonics
C3b = Big opsonin; C3a = Small anaphylatoxin C3b (larger fragment) stays bound to pathogen → opsonin. C3a (smaller fragment) diffuses away → anaphylatoxin. Same rule applies to C5b vs C5a. Use this when distinguishing complement fragments by size and function. OPSONIN = Coat & Enhance (OPSonin = Opsonize = coat) Opsonic fragments (C3b, iC3b) coat the pathogen surface and enhance phagocyte binding. Anaphylatoxins (C3a, C5a) diffuse and trigger inflammation. Recall this when asked about complement's role in phagocytosis vs inflammation.
NBE Trap
NBE pairs C3 with all its fragments (C3a, C3b, iC3b) to test whether students confuse the opsonic function (C3b/iC3b) with the inflammatory function (C3a). The trap is especially potent because C3a is generated from the same cleavage event as C3b, making students think they share the same role.
Clinical Pearl
In Indian clinical practice, patients with C3 nephritic factor (a stabilizing autoantibody) develop membranoproliferative glomerulonephritis due to uncontrolled C3 activation and deposition—demonstrating that excessive C3b coating of glomerular basement membrane, while normally protective against pathogens, becomes pathogenic in the kidney. This illustrates why C3b's opsonizing power must be tightly regulated.
_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 2 (Inflammation); Harrison's Principles of Internal Medicine, Ch. 308 (Complement System)_